Innoviva Total Liabilities and Share Holders Equity 2012-2026 | INVA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Innoviva total liabilities and share holders equity from 2012 to 2026. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.

Innoviva Total Liabilities and Share Holders Equity 2012-2026 | INVA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Innoviva total liabilities and share holders equity from 2012 to 2026. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.

Related Stocks
Company Name	Market Cap
Eli Lilly (LLY)	$887.6B
Johnson & Johnson (JNJ)	$574.4B
AbbVie (ABBV)	$367.7B
Roche Holding AG (RHHBY)	$318.8B
Merck (MRK)	$299.9B
Novartis AG (NVS)	$294B
Novo Nordisk (NVO)	$167.5B
Pfizer (PFE)	$153.1B
Sanofi (SNY)	$114B
Bayer (BAYRY)	$46.2B